Amwill Health Care IPO Details: Price, Dates & Financials
The Amwill Health Care IPO GMP strength score is 8 out of 10, which the dashboard rates as Strong. The Amwill Health Care IPO valuation is tagged Good. The Amwill Health Care IPO QIB category is reserved for 18.99% of the offer. The Amwill Health Care IPO NII/HNI category is reserved for 38% of the offer. The Amwill Health Care IPO Retail (RII) category is reserved for 38% of the offer. Live subscription numbers for the Amwill Health Care IPO are not yet available, and amounts are calculated at the upper price band of ₹111.
| Category | Sub (x) | Offered | Bid For |
|---|---|---|---|
| QIB | — | 1,026,000 (19%) | — |
| NII / HNI | — | 2,053,200 (38%) | — |
| Retail (RII) | — | 2,053,200 (38%) | — |
| Market Maker | — | 271,200 (5%) | — |
| Total | — | 5,403,600 (100%) | — |
* Amount calculated at upper price band (₹111) · ** Total includes all investor categories
- 1 Initiation of Refund 11 Feb 2025
- 2 Credit of Shares to Demat 11 Feb 2025
- Retail allocation is good at 38% of the total offering.
- HNI/NII demand is strong at 38%.
- Institutional (QIB) interest is strong at 19%.
- The IPO P/E of 17x reflects a good valuation relative to typical market ranges.
- Pre-issue EPS of ₹8 compares to post-issue EPS of ₹7 after dilution.
This IPO shows strong fundamentals and healthy investor demand. Research the business model and compare with sector peers before applying.
GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.